ClinicalTrials.gg
RecruitingNCT07938684Updated Nov 16, 2026

The Effect of an AI-Powered, Interactive Learning Tool on Knowledge of Infection Control

An interventional study of Interactive training in Infection Control, Artificial Intelligence (AI) and Learning, sponsored by Bilecik Seyh Edebali Universitesi. Recruiting at 1 site in Turkey (Türkiye). Open to participants aged 17 Years to 60 Years, including healthy volunteers. Per ClinicalTrials.gov, last updated 2026-11-16.

Sponsored by Bilecik Seyh Edebali Universitesi · Not applicable, Interventional, and Other

From the registry’s dates

  • Started Oct 2026; still recruiting 1 month later.
Updated Nov 16, 2026Newly registeredGo to Updates ↓

Help build ClinicalTrials.gg — short surveys, remote interviews or testing, in your language. Take part →

Phase
Not applicable
Study type
Interventional
Enrollment
90
Allocation
Randomized
Ages
17 Years to 60 Years
Sex
All
01

Study summary

Practical exercises will be conducted using an AI-supported, interactive learning tool to enhance nursing students' knowledge of infection control and improve their learning skills.

Read the detailed description

This study aims to investigate the impact of an AI-supported clinical case simulation and interactive learning tool on nursing students' knowledge of infection control, motivation, and self-efficacy. The study is unique in its integration of AI-supported clinical case simulation and interactive learning within the context of infection control. Interactive methods will be incorporated into training on hand hygiene, the use of personal protective equipment, isolation protocols, and cross-contamination. It is anticipated that the study will make a significant contribution to the literature and serve as a guide for educators.

02

Conditions studied

  • Infection Control
  • Artificial Intelligence (AI)
  • Learning

Keywords

  • Interactive Learning
  • Infection Control
  • Artificial Intelligence
  • Nursing Students
03

In context

Lead sponsor

Bilecik Seyh Edebali Universitesi is the lead sponsor of 63 studies on the registry; 28 are open to participants now.

Counted across the registry records on this site, refreshed daily.

04

Who can participate

Ages eligible
17 Years to 60 Years
Sexes eligible
All
Accepts healthy volunteers
Yes

Go through the criteria one by one — yes, no or not sure — and take the list to your doctor or the study team. Kept in this browser only.

Inclusion criteria

  • Receiving information on infection control for the first time
  • Participating in the final test and follow-up test

Exclusion criteria

Exclusion Criteria:

  • Having previously received training in infection control
  • Failure to participate in the most recent test and follow-up test
05

Study design

Phase
Not applicable
Primary purpose
Other
Allocation
Randomized
Intervention model
Parallel assignment
Masking
None (open label)
Enrollment
90 participants (estimated)

Study arms

  • Experimental
    The Effect of an AI-Powered, Interactive Learning Tool on Knowledge Levels

    Changes in Students' Knowledge Levels

    Other: Interactive training

  • Experimental
    The Effect of an AI-Powered, Interactive Learning Tool on Students' Self-Directed Learning Skills

    The Effect of an AI-Powered, Interactive Learning Tool on Students' Self-Directed Learning Skills

    Other: Interactive training

Interventions

  • OtherInteractive training

    Interactive education for nursing students

06

What researchers measure

Primary outcomes

  1. Comparison of pre-test, post-test, and follow-up test results

    Knowledge Levels

    Time frame: 6 week

  2. Self-Directed Learning Skills

    Brief and Universal Self-Efficacy Scale for Clinical Skills

    Time frame: 5 week

07

Study locations

1 of 1 sites recruiting
08

Timeline

1 registry update since Sep 25, 2026
ElapsedEstimatedEstimated, not yet reached

Started Oct 2026 (actual). Primary completion is estimated for Nov 2026, 1 month after the start.

How these figures are worked out, and which studies are left out of them.

Registered
Oct 20, 2026
First posted
Nov 16, 2026
StartActual
Oct 15, 2026
Primary completionEst.
Nov 30, 2026
CompletionEst.
Dec 15, 2026
Last update
Nov 16, 2026
What these dates mean
Start.
When the first participant enrolled; while estimated, when the study expects to open to recruitment.
Primary completion.
When the last participant was examined or treated to collect data for the study's main question, its primary outcome. A study that stopped early gives the date its data collection stopped.
Completion.
When the last participant's last visit took place, for every outcome, secondary ones and side effects included: the end of the study. Often later than primary completion, sometimes the same day.
Actual and Est.
Actual means the registry says the date has happened. Est. (estimated) is a date the sponsor plans or expects. It can still move, and the sponsor is expected to change it to actual once it has passed.
Registered
First appeared on the registry. No changes since
Nov 16, 2026
Show all 1 update
  1. Nov 16, 2026
    First appeared on the registry

From the registry record's own update history. This site started tracking changes on Sep 25, 2026; for anything earlier, see the record history on ClinicalTrials.gov ↗

09

Registry details

Key details

Study ID
NCT07938684
Lead sponsor
Bilecik Seyh Edebali Universitesi
Responsible party
Sponsor
First posted
Nov 16, 2026
Start date
Oct 15, 2026
Primary completion
Nov 30, 2026 (estimated)
Completion
Dec 15, 2026 (estimated)
Last update
Nov 16, 2026

Study contacts

Aysun Acun, Associate Professor, Ph.D.
Contact
aysun.acun@bilecik.edu.tr
05072104506
Aysun Acun, Ph.D
Contact
aysun.acun@bilecik.edu.tr
05072104506
Aysun Acun, Ph.D.
study director · Bilecik Seyh Edebali Universitesi

Oversight

Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No
View the source record on ClinicalTrials.gov ↗

Interested in this study?

Eligibility is decided by the study team. Share this record with your doctor or contact the team directly.

Contact study team

Follow this study

Get an email when the registry record changes — status, dates, results — or when someone posts here.

Sign in to follow

Discussion

Questions and observations about this study, from anyone following it. Not medical advice, and not a channel to the study team — their contact details are on the registry record.

Sign in to join the discussion. Reading takes no account; posting does. You choose a display name, and a pseudonym is the default.

Nothing here yet. If you are running this trial, taking part in it, or weighing whether to, this is the place to say so.

Start the discussion